Delivery Order SPE2DB24D9144-SPE2DB24FCMJB

Award Date 8/2/24
Potential Completion Date 8/23/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued at up to $499,999,999. The contract provides for the delivery of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $24,623.65. The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency, to support the recurring pharmaceutical and medical supply needs of military health facilities worldwide. The contract covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order with a ceiling value of $8,339.18. It was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract covers the delivery of various medications, including...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $11,587.21. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order contract with a ceiling value of $11,449.78. The contract is for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities and VA medical centers nationwide. The contract is part of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order with a ceiling value of $12,680.98. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to provide a wide range of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at up to $499,999,999. The contract is for the supply of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order contract with a ceiling value of $4,642.20. The contract was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to provide the U.S. Department of Defense (DoD) with a variety of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The award is under the DLA's SPE2DB...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract is for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. The...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $4,211.52 for the supply of pharmaceutical products to the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract has a firm fixed-price pricing structure and does not have a set-aside designation. The contract covers a wide range of pharmaceuticals, including both branded and generic prescription drugs,...
  • SPE2DB24D9144
    Indefinite Delivery Contract
  • SPE2DB24D9144-SPE2DB24FCMJB
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order with a ceiling value of $4,736.00. The award was made by the Defense Logistics Agency (DLA), a defense agency, to fulfill the recurring medical supply needs of military health facilities worldwide.

The contract covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. Specific items include flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives such as Mirena and Nexplanon implants, oncology drugs, and specialty medications.

This award is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities. The contract does not have a set-aside designation.

Generated 11/1/24, 10:18 AM